Diagnostic imaging  

GE opens development centre in India to study medical diagnostic products

13 July 2006

Bangalore, India. GE Healthcare, (part of GE — NYSE:GE) today announced the opening of its first Integrated Development Centre (IDC) at Manipal Hospital in Bangalore, India. The centre is part of the strategic development of GE's Global Clinical Studies Program.

Under the terms of the collaboration, physicians at Manipal Hospital will act as study investigators and provide clinical and imaging services and administration in the hospital.

Manipal Hospital will conduct clinical research trials using a wide range of GE Healthcare's diagnostic imaging technologies including its LightSpeed VCT, Discovery STe 16 slice PET/CT scanner, Dual Head Gamma Camera with CT (SPECT/CT) and TwinSpeed High Definition Magnetic Resonance (HDMR) imaging system.

The IDC in Bangalore will play a crucial role in GE Healthcare's ongoing global clinical research program and support its vision of "Early Health" by helping to bring new diagnostic imaging agents to market and working to address serious unmet medical needs in oncology, neurology and cardiology.

The IDC in Bangalore is expected to conduct around 1,000 scans annually as part of the planned clinical trials and will be part of a series of global multi-country clinical studies in the United States, the European Union and several other countries. Over time, GE Healthcare will create more IDCs in key strategic locations globally.

Information obtained from Bangalore will be combined with data from other centres globally and contribute towards the development of new contrast and molecular imaging agents or new indications for existing agents.

The first studies will focus on Visipaque (iodixanol) an isosmolar contrast agent that was launched globally by GE Healthcare in 1996. Visipaque has been used in millions of X-ray and computer tomography procedures to date. Contrast agents are used during medical diagnostic procedures to provide image enhancement of tissues and organs. Future studies will be extended to cover the company's entire diagnostic imaging portfolio.

The collaboration between GE Healthcare and Manipal Hospital will benefit local patients in a number of ways. In particular, the investment in imaging infrastructure will increase access to the most advanced medical diagnostic technology available.

Dan Peters, President and CEO of Medical Diagnostics at GE Healthcare said, "The clinical studies in India are a key part of our global strategy. We want to use our unique abilities in biology and engineering to develop novel imaging agents that will provide groundbreaking molecular diagnostic options for physicians and their patients. The research efforts of GE Healthcare's Medical Diagnostics R&D team are currently focused on functional and molecular imaging agents that help doctors evaluate the physiology of disease and make treatment decisions earlier with confidence."

Mr. V. Raja, President, GE Healthcare India, said: "We are extremely pleased to collaborate with Manipal Hospital which is one of India's most respected institutions. GE Healthcare and Manipal Hospital are both driven by a desire to change the future of healthcare by helping patients experience "Early Health", which focuses on early diagnosis rather than late disease. Together, we will be able to create one of the most advanced Integrated Development Centers in the world. We will also be tapping into the resources of the GE Global Research Centre here in Bangalore, as well the expertise of our global Medical Diagnostics team."

To top

To top